4//SEC Filing
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4
Accession 0001193805-24-001275
CIK 0001861560other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:08 PM ET
Size
30.5 KB
Accession
0001193805-24-001275
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Flynn James E
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
DEERFIELD MANAGEMENT CO /NY
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
DEERFIELD PARTNERS, LP
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
Deerfield Mgmt HIF, L.P.
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
Deerfield Private Design Fund IV, L.P.
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
Deerfield Healthcare Innovations Fund, L.P.
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
Deerfield Mgmt IV, L.P.
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
DEERFIELD CAPITAL LP
Director10% OwnerOther
Transactions
- Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Private Design Fund IV, L.P.) - Sale
Class A Common Stock
2024-10-22$97.75/sh−1,000,000$97,750,000→ 8,670,512 total(indirect: Through Deerfield Healthcare Innovations Fund, L.P.)
Holdings
- 650,000(indirect: Through Deerfield Partners, L.P.)
Class A Common Stock
Footnotes (2)
- [F1]This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P.
- [F2]In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001009258
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 4:08 PM ET
- Size
- 30.5 KB